Wilmington, DE, United States of America

Vivian Y Bi

This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vivian Y Bi. Retrieved from https://idiyas.com/inventor/vivian-y-bi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 18.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Vivian Y Bi: Innovator in Pharmaceutical Sciences

Introduction

Vivian Y Bi is a prominent inventor based in Wilmington, DE (US). She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel compounds and formulations.

Latest Patents

Vivian holds a patent for "Crystalline forms - 11-piperazin-1-yldibenzo[b,f][1,4]thiazepine, compositions thereof, preparations thereof, formulations thereof, prodrugs thereof and pharmaceutical uses thereof." This patent showcases her innovative approach to drug formulation and development.

Career Highlights

Vivian is currently associated with AstraZeneca AB, where she applies her expertise in pharmaceutical research. Her work focuses on creating effective therapeutic solutions that can improve patient outcomes.

Collaborations

Vivian has collaborated with notable colleagues, including Simon Nicholas Black and Scott W Grimm. These partnerships have further enhanced her research and development efforts in the pharmaceutical industry.

Conclusion

Vivian Y Bi is a dedicated inventor whose work in pharmaceutical sciences continues to impact the field positively. Her innovative contributions and collaborations highlight her commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…